3 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow DryVax vaccine: new trials by email Literature Review of DryVax vaccine trials Research Report on DryVax vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults ACAM3000 MVA Vaccine - Smallpox | Phase 1 | Completed | Sanofi Pasteur, a Sanofi Company | 110 | 2004-04-01 | 2014-01-13 |
| Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults ACAM2000 Smallpox Vaccine, Vaccinia virus (calf lymph) smallpox vaccine: Dryvax® - Smallpox | Phase 2 | Completed | Emergent BioSolutions | 357 | 2003-01-01 | 2024-03-18 |
| Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination ACAM1000, vaccinia virus (calf lymph) smallpox vaccine: Dryvax - Smallpox | Phase 2 | Terminated | Sanofi Pasteur, a Sanofi Company | 274 | 2002-09-01 | 2014-01-22 |
| A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults Dryvax vaccine - Smallpox | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-08-27 |
Sanofi Pasteur, a Sanofi Company (2) · Emergent BioSolutions (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (4)